C110. THE FUTURE OF LUNG CANCER BIOMARKERS: WHERE SHOULD WE LOOK?

查看最新文献

121

C110. THE FUTURE OF LUNG CANCER BIOMARKERS: WHERE SHOULD WE LOOK? - 最新文献

Novel Multiplexed Plasma Biomarkers and Clinical Factors Augment Risk Assessment for Indeterminate Pulmonary Nodules in Former Smokers

Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a7452 A. Fish, A. Vachani, P. Massion, S. Antic, N. Trivedi, J. K. Brown, T. Rubenstein, A. D. Rostykus, M. Beggs, Hongfeng Yu, L. Carbonell, M. Arjomandi

Effect of the ABCG2 C421A Polymorphism on Plasma Concentration of Gefitinib

Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5821 Sho Sakamoto, Kazuhiro Sato, Y. Okuda, Y. Izumiya, Naho Kumagai, Kazuhisa Sudo, Mariko Asano, M. Takeda, M. Sano, K. Nakayama

TOP2A and HER2neu Evaluation in Malignant Pleural Mesothelioma

Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5824 F. Abou El-Kasem, M. Rahouma, Iman Loay, O. Badawi, Mohamed S. Kamel, Dina A. Ibrahim, G. Ghaly, M. Amin, A. Abdelrahman

查看全部

免责声明：
本页显示期刊或杂志信息，仅供参考学习，不是任何期刊杂志官网，不涉及出版事务，特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题，请联系我们，邮箱：info@booksci.cn，我们会认真核实处理。